title: Complete response to topotecan of recurrent fallopian tube carcinoma.
abstract: OBJECTIVE
  To describe the first complete response of recurrent Fallopian tube carcinoma to topotecan.
  
  
  METHODS
  A patient with recurrent Fallopian tube carcinoma previously treated with paclitaxel (Taxol) and carboplatin is described.
  
  
  RESULTS
  This patient demonstrated a complete clinical response to topotecan. Radiographic and CA-125 measurements were used to determine response. Response was noted after four cycles and a complete response demonstrated after six treatments.
  
  
  CONCLUSIONS
  Topotecan appears active in recurrent Fallopian tube carcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, Jefferson Medical College, Philadelphia, Pennsylvania, 19107, USA.
authors.forename: C J
authors.initials: CJ
authors.lastname: Dunton
authors.forename: J
authors.initials: J
authors.lastname: Neufeld
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018394:CA-125 Antigen / Q000032:analysis; D005185:Fallopian Tube Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D019772:Topotecan / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D018394:CA-125 Antigen; D019772:Topotecan